BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16312215)

  • 1. Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker.
    Sánchez-Puig JM; Blasco R
    Biotechniques; 2005 Nov; 39(5):665-6, 668, 670 passim. PubMed ID: 16312215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of recombinant MVA using F13L selection.
    Sánchez-Puig JM; Lorenzo MM; Blasco R
    Methods Mol Biol; 2012; 890():93-111. PubMed ID: 22688762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.
    Bryk P; Brewer MG; Ward BM
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.
    Husain M; Moss B
    J Virol; 2002 Aug; 76(15):7777-89. PubMed ID: 12097590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes.
    Antoshkina IV; Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
    Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
    Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal.
    Huemer HP; Strobl B; Shida H; Czerny CP
    J Virol Methods; 2000 Mar; 85(1-2):1-10. PubMed ID: 10716333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
    Roper RL; Moss B
    J Virol; 1999 Feb; 73(2):1108-17. PubMed ID: 9882312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara.
    Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R
    Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Set of vectors for the expression of histidine-tagged proteins in vaccinia virus recombinants.
    Galindo I; Lorenzo MM; Blasco R
    Biotechniques; 2001 Mar; 30(3):524-6, 528-9. PubMed ID: 11252789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge.
    Vliegen I; Yang G; Hruby D; Jordan R; Neyts J
    Antiviral Res; 2012 Jan; 93(1):160-6. PubMed ID: 22138484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.
    Geada MM; Galindo I; Lorenzo MM; Perdiguero B; Blasco R
    J Gen Virol; 2001 Nov; 82(Pt 11):2747-2760. PubMed ID: 11602786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence and analysis of a swinepox virus homologue of the vaccinia virus major envelope protein P37 (F13L).
    Bárcena J; Lorenzo MM; Sánchez-Puig JM; Blasco R
    J Gen Virol; 2000 Apr; 81(Pt 4):1073-85. PubMed ID: 10725435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.
    Roscoe F; Xu RH; Sigal LJ
    J Virol; 2012 Dec; 86(24):13501-7. PubMed ID: 23035222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.